Market Quotes

2277 items in section

Refresco to Acquire SunOpta for $6.50 Per Share in Cash

Beverage manufacturing giant Refresco has reached a definitive agreement to acquire SunOpta, a leader in plant-based food and beverage supply chains, for $6.50 per share in cash. The deal represents a significant premium over SunOpta’s recent market valuation and is designed to cement Refresco’s dominance in the North American alternative dairy sector.

Bloom Energy Rallies as AI Demand Drives Record Revenue and Outlook

Bloom Energy shares surged 13% in pre-market trading after the power-generation firm reported fourth-quarter revenue that significantly outpaced Wall Street estimates. The company attributed the growth to insatiable energy demand from artificial intelligence hyperscalers, issuing a bullish financial outlook that suggests the data center boom is providing a long-term tailwind for its fuel-cell technology.

Molina Healthcare Shares Crater as Medicaid Costs Squeeze Outlook

Molina Healthcare shares plummeted 31% on Friday after the insurer issued a full-year profit forecast that fell significantly short of Wall Street expectations. The company cited surging Medicaid expenses and underperformance in its prescription drug business as primary drivers for the downward revision, sparking a massive sell-off.

Impinj Shares Plunge 25% Following Earnings Miss and Weak Outlook

Impinj Inc. shares cratered in pre-market trading Friday after the RFID technology specialist missed quarterly earnings expectations and issued a cautious forecast for the first quarter. Despite a slight revenue beat, the company’s narrow miss on adjusted profit and projected losses triggered a sharp reversal for a stock that had gained 43% over the past year.

Once Upon a Farm Prices IPO at $18 Ahead of NYSE Debut

Once Upon a Farm, the Berkeley-based producer of organic children’s food, is set to begin trading on the New York Stock Exchange this Friday after pricing its initial public offering at $18 per share. The valuation sits exactly at the midpoint of the company's projected range, signaling steady investor interest in the premium health-food sector.

Kongsberg Shares Jump as Missile Demand Drives Record Q4 Performance

Kongsberg Gruppen shares surged as much as 17% on Friday after the Norwegian defense contractor reported fourth-quarter earnings that significantly outpaced market expectations. Driven by a global rush for air defense systems and missiles, the company posted a 21% revenue increase and doubled its core earnings, underscoring the defense industry's rapid expansion amid heightened geopolitical tensions.

Carlyle Group Revenue Surges 84% as Assets Reach $477 Billion

Carlyle Group reported a significant jump in fourth-quarter profit and revenue, capping a record 2025 as the private-equity giant expanded its total assets under management to $477 billion. Driven by robust fundraising and performance that surpassed Wall Street expectations, the firm reported a sharp increase in net income compared to the previous year.

Hub Group Shares Plunge 30% After Accounting Error Delays Results

Hub Group shares plummeted in premarket trading Friday after the logistics provider delayed its annual financial report and disclosed a $77 million accounting error. The company issued preliminary 2025 results alongside the delay, projecting a revenue decline to approximately $3.7 billion as it grapples with understated transportation costs from the first nine months of the year.

Metlen Energy Shares Plunge Following 2025 Earnings Downgrade

Metlen Energy & Metals shares tumbled on Friday after the U.K.-based industrial group slashed its 2025 earnings outlook, citing significant cost overruns and stalled asset sales. The revision marks a sharp pivot from previous forecasts that saw the company crossing the billion-euro profit threshold.

FDA Fast-Tracks Pfizer’s Hemophilia Drug for Pediatric Use

Pfizer announced on Friday that the U.S. Food and Drug Administration has granted priority review for an expanded application of Hympavzi, its hemophilia treatment. The regulatory move targets two high-need patient groups, including younger children, with a final decision expected in the second quarter.

Piper Sandler Sets 4-for-1 Stock Split and $5 Special Dividend

Piper Sandler Companies announced a 4-for-1 stock split and a substantial special dividend on Friday, moves designed to broaden the investment bank’s shareholder base and return excess capital. The Minneapolis-based firm confirmed the split will take effect after the close of trading on March 23, with shares shifting to the adjusted price structure the following business day.

Ajinomoto Stock Hits 30-Year High on Profit Surge and AI Demand

Ajinomoto Co. shares soared more than 13% on Friday, marking their best single-day performance since 1990, after the Japanese food giant raised its earnings guidance and reported strong growth in its specialized materials division. The rally followed an 8.9% rise in nine-month net profit, with the company now projecting a massive 85% jump in earnings for the fiscal year ending March 2026.

Vinci Shares Surge on Record Cash Flow and Dividend Hike

Shares in French infrastructure giant Vinci climbed 6.4% after the company reported record free cash flow and a revenue beat for the 2025 fiscal year. The group posted revenue of €74.60 billion, outperforming analyst expectations and signaling resilience despite a turbulent global macroeconomic backdrop.

Thailand Election: Markets Brace for Policy Limbo and Fiscal Strain

Thailand heads to the polls this Sunday in a high-stakes general election that investors fear could trigger prolonged political gridlock and stall a fragile economic recovery. With a fragmented coalition government the most likely outcome, analysts warn that delays in budget approvals and structural reforms may further depress growth in Southeast Asia’s second-largest economy.

Sintokogio Returns to Profit as Nine-Month Revenue Surges

Japanese industrial equipment manufacturer Sintokogio Ltd. reported a return to profitability for the first nine months of the fiscal year, driven by a sharp increase in group revenue. For the period ending December 31, the company posted a net profit of ¥678 million, successfully reversing a loss from the previous year as operating margins improved across its core business units.

Uber and WeRide to Launch 1,200 Robotaxis Across the Middle East

WeRide is accelerating its global footprint through a strategic partnership with Uber, planning to deploy at least 1,200 autonomous vehicles across major Middle Eastern hubs by 2027. The initiative will integrate WeRide’s self-driving fleet into the Uber app in Abu Dhabi, Dubai, and Riyadh, marking a significant escalation in the race for autonomous ride-hailing dominance outside of China.

Ushio Inc. Net Profit Slides 30% Despite Operating Growth

Tokyo-based lighting specialist Ushio Inc. reported a sharp decline in net profit for the nine months ending December 31, 2024, even as the company saw a modest improvement in its core operating performance. The group’s bottom line fell to ¥4.04 billion, down from ¥5.75 billion a year earlier, reflecting broader pressures on pretax income.

OncoTherapy Science Net Loss Widens to ¥783 Million

Japanese biotechnology firm OncoTherapy Science Inc. reported a widened net loss of ¥783 million for the nine months ended Dec. 31, 2024, as the company struggled to translate modest revenue growth into improved profitability.